Join us for a conversation with Saharsh, Vice Chairman and Managing Director of Neuland. After 18 years with the company, including building its CDMO business, he’s stepping into the CEO role and shares his immediate priorities: closer client–team collaboration, timely delivery of major R&D and facility investments, balancing growth between generic APIs and an expanding CDMO business, and strengthening supply‑chain resilience.
TWENTYFOURSEVENBIOPHARMA